Evolving Landscape of US Food and Drug Administration Drug Approval in the Era of Precision Oncology: Finding the Right Balance Between Access and Safety.
Publication
, Journal Article
Kuderer, NM; Lyman, GH
Published in: J Clin Oncol
June 20, 2018
Duke Scholars
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
June 20, 2018
Volume
36
Issue
18
Start / End Page
1773 / 1776
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Randomized Controlled Trials as Topic
- Precision Medicine
- Oncology & Carcinogenesis
- Neoplasms
- Humans
- Drug Approval
- Antineoplastic Agents
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Kuderer, N. M., & Lyman, G. H. (2018). Evolving Landscape of US Food and Drug Administration Drug Approval in the Era of Precision Oncology: Finding the Right Balance Between Access and Safety. J Clin Oncol, 36(18), 1773–1776. https://doi.org/10.1200/JCO.2018.78.5592
Kuderer, Nicole M., and Gary H. Lyman. “Evolving Landscape of US Food and Drug Administration Drug Approval in the Era of Precision Oncology: Finding the Right Balance Between Access and Safety.” J Clin Oncol 36, no. 18 (June 20, 2018): 1773–76. https://doi.org/10.1200/JCO.2018.78.5592.
Kuderer NM, Lyman GH. Evolving Landscape of US Food and Drug Administration Drug Approval in the Era of Precision Oncology: Finding the Right Balance Between Access and Safety. J Clin Oncol. 2018 Jun 20;36(18):1773–6.
Kuderer, Nicole M., and Gary H. Lyman. “Evolving Landscape of US Food and Drug Administration Drug Approval in the Era of Precision Oncology: Finding the Right Balance Between Access and Safety.” J Clin Oncol, vol. 36, no. 18, June 2018, pp. 1773–76. Pubmed, doi:10.1200/JCO.2018.78.5592.
Kuderer NM, Lyman GH. Evolving Landscape of US Food and Drug Administration Drug Approval in the Era of Precision Oncology: Finding the Right Balance Between Access and Safety. J Clin Oncol. 2018 Jun 20;36(18):1773–1776.
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
June 20, 2018
Volume
36
Issue
18
Start / End Page
1773 / 1776
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Randomized Controlled Trials as Topic
- Precision Medicine
- Oncology & Carcinogenesis
- Neoplasms
- Humans
- Drug Approval
- Antineoplastic Agents
- 3211 Oncology and carcinogenesis